The article has been withdrawn by agreement between the editors and publisher of Recent Patents on Anti-Cancer Drug Discovery. The authors are not responding to the editor's requests to provide the language-edited version. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php. Bentham Science Disclaimer It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submit-ting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

中文翻译：

---

退出通知：ERRα 表达水平与病理分级、总生存期和癌症类型之间的相关性：对 150 名乳腺癌患者的队列研究

该文章已根据《抗癌药物发现的最新专利》的编辑和出版商之间的协议撤回。作者没有回应编辑提供语言编辑版本的要求。Bentham Science 对由此可能造成的任何不便向该杂志的读者表示歉意。可以在 https://benthamscience.com/editorial-policies-main.php 上找到关于文章撤回的边沁编辑政策。Bentham Science 免责声明 提交给该期刊的手稿尚未发表，并且不会同时提交或在其他地方发表，这是发表的条件。此外，任何在别处发表的数据、插图、结构或表格都必须报告，并且必须获得复制的版权许可。严禁抄袭，通过提交文章发表，作者同意出版商有合法权利对作者采取适当的行动，如果发现抄袭或捏造信息。通过提交手稿，作者同意，如果文章被接受发表，其文章的版权将转移给出版商。